Inhibrx Biosciences Inc. (INBX)
NASDAQ: INBX
· Real-Time Price · USD
31.84
2.14 (7.21%)
At close: Sep 25, 2025, 3:59 PM
32.20
1.11%
After-hours: Sep 25, 2025, 05:09 PM EDT
7.21% (1D)
| Bid | 28.37 |
| Market Cap | 461.28M |
| Revenue (ttm) | 1.4M |
| Net Income (ttm) | -163.69M |
| EPS (ttm) | -16.57 |
| PE Ratio (ttm) | -1.92 |
| Forward PE | -3.1 |
| Analyst | n/a |
| Dividends | n/a |
| Ask | 40 |
| Volume | 103,612 |
| Avg. Volume (20D) | 126,563 |
| Open | 29.56 |
| Previous Close | 29.70 |
| Day's Range | 29.29 - 31.96 |
| 52-Week Range | 10.80 - 31.96 |
| Beta | 0.31 |
| Ex-Dividend Date | n/a |
About INBX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol INBX
Website n/a
4 months ago
+10.89%
Inhibrx Biosciences shares are trading higher afte...
Unlock content with
Pro Subscription
10 months ago · seekingalpha.com
Inhibrx Biosciences: Reincorporated And Trying To Find A Niche With Unique PlatformINBX's two main pipeline candidates, INBRX-109 and INBRX-106, are entering critical late-stage trials with data readouts expected in mid- to late-2025. INBRX-109 targets DR5 in solid tumors, showing p...